Ceribell CBLL 深 沪
已收盘 10-30 16:00:00 美东时间
26.58
-1.240
-4.46%
华盛通- 最 高27.61
- 今 开27.48
- 成交量 58.27万股
- 最 低 26.012
- 昨 收 27.82
- 总市值 10.20亿
- 52周最高 28.19
- 市盈率 静 --
- 换手率 1.52%
- 52周最低 11.42
- 委 比 65.28%
- 总股本 3837.81万
- 历史最高 32.7489
- 量 比 0.93
- 振 幅 5.74%
- 历史最低 10.01
- 每 手 1
- 风险率 3.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ceribell收涨2.2%，成交额1126.08万美元
10月30日，Ceribell（CBLL）收涨2.2%，报27.82美元，成交额1126.08万美元，市值10.68亿美元。 行情数据 • 开盘价：27.4美元...
10-30 05:44
Ceribell收平，成交额2018.67万美元
10月29日，Ceribell（CBLL）收平，报27.22美元，成交额2018.67万美元，市值10.45亿美元。 行情数据 • 开盘价：27.22美元 •...
10-29 05:43
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Ceribell, Inc. announced that its CFO, Scott Blumberg, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York City on November 11, 2026. The event will take place at 7:00 a.m. PST / 10:00 a.m. EST. A live and archived webcast will be available on Ceribell's Investor Relations website. Ceribell is a medical technology company focused on improving the diagnosis and managemen...
10-28 20:05
Ceribell收涨6.46%，成交额1626.92万美元
10月21日，Ceribell（CBLL）收涨6.46%，报27.68美元，成交额1626.92万美元，市值10.62亿美元。 行情数据 • 开盘价：26美元...
10-21 05:45
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Ceribell, Inc. announced it will release third-quarter 2026 financial results on November 3, 2026, followed by a conference call at 1:30 p.m. PT / 4:30 p.m. ET. The call can be accessed via phone or webcast. Ceribell, a medical tech company, develops an AI-powered EEG system for neurological patients and is headquartered in Sunnyvale, California.
10-20 20:05
Ceribell收跌9.41%，成交额1041.29万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:48
美股大行评级 | 潜在涨幅405.62%！Inventiva(IVA)获Truist Securities上调目标价至18美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持Inventiva"买入"评级，目标价从13美元升至18美元；富瑞：维持Sagimet Biosciences"买入"评级，目标价从25美元升至26美元
10-05 16:26
TD Cowen Maintains Buy on CeriBell, Raises Price Target to $33
TD Cowen analyst Joshua Jennings maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $29 to $33.
10-02 22:20
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Ceribell, Inc. announced FDA clearance for new software updates to its EEG system, simplifying brain activity interpretation for clinicians across all patient ages. The updates include Alpha-Delta Ratio & Relative Alpha Trending, Burst Suppression Monitoring, and Amplitude-Integrated EEG, enabling earlier detection of brain distress and improved interventions. The features, available via automatic updates in early 2027, reflect Ceribell's commitm...
09-30 11:00
美股大行评级 | Adobe绩后获多家大行齐升目标价！最高看多至270美元；甲骨文绩后现多空分歧
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从10美元升至10.5美元；摩根士丹利：维持Aurora Innovation"超配"评级，目标价从14美元升至18美元
09-14 16:05
